TerrAscend (TSNDF) Return on Capital Employed (2022 - 2026)
TerrAscend (TSNDF) posted quarterly Return on Capital Employed of 8.51% for Q1 2026, up 57.0% year-over-year from 5.42% in Q1 2025, and down 3.57% quarter-over-quarter from 8.82% in Q4 2025.
TerrAscend (TSNDF) Return on Capital Employed (2022 - 2026) Analysis & Trends
TerrAscend (TSNDF) has reported Return on Capital Employed for 5 consecutive years, with 8.51% the latest figure, recorded in Q1 2026.
- In Q1 2026, Return on Capital Employed rose 57.0% year-over-year to 8.51%; the TTM figure through Mar 2026 stood at 8.51% (up 57.0% YoY), while the FY2025 annual figure was 8.36%, up 123.0% from the prior year.
- Return on Capital Employed eased to 8.51% in Q1 2026 per TSNDF's latest filing, from 8.82% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 17.54% in Q3 2023 and bottomed at 142.21% in Q2 2023.
- Historically, Return on Capital Employed has averaged 12.76% across 5 years, with a median of 6.59% in 2024.
- Annual changes were most pronounced in 2023 — Return on Capital Employed tumbled 14075 bps — and 2024, when it surged 14895 bps.
- TerrAscend's Return on Capital Employed stood at 58.36% in 2022, then jumped by 110 bps to 6.02% in 2023, then climbed by 9 bps to 6.59% in 2024, then surged by 34 bps to 8.82% in 2025, then dropped by 4 bps to 8.51% in 2026.
- Business Quant data shows TSNDF's Return on Capital Employed at 8.51% in Q1 2026, 8.82% in Q4 2025, and 9.44% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 6.60% |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 17.16% |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 6.07% |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 22.04% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -0.29% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 18.67% |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 5.52% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | TerrAscend | 187.35 Mn | 145.23 Mn | 36.25 Mn | 8.67% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.67% |
| Mar 31, 2026 | 8.51% |
| Dec 31, 2025 | 8.82% |
| Sep 30, 2025 | 9.44% |
| Jun 30, 2025 | 8.52% |
| Mar 31, 2025 | 7.94% |
| Dec 31, 2024 | 6.59% |
| Sep 30, 2024 | 4.94% |
| Jun 30, 2024 | 6.74% |
| Mar 31, 2024 | 6.93% |
| Dec 31, 2023 | 6.02% |
| Sep 30, 2023 | 17.54% |
| Jun 30, 2023 | -142.21% |
| Mar 31, 2023 | -59.42% |
| Dec 31, 2022 | -58.36% |
| Sep 30, 2022 | -49.12% |
| Jun 30, 2022 | -1.46% |
| Mar 31, 2022 | 1.65% |